Improving adherence to medications in pediatric liver transplant recipients

E Shemesh1, R A Annunziato, B L Shneider

  • 1Department of Psychiatry, Mount Sinai Medical Center, New York, NY, USA. Shemesh@email.chop.edu

Insights

This study shows that increased clinic visits can improve medication adherence in pediatric liver transplant patients. The intervention led to fewer high liver enzyme levels and rejection episodes, suggesting a promising approach for better patient outcomes.

Area of Science:

  • Pediatric Gastroenterology
  • Transplant Medicine
  • Clinical Pharmacology

Background:

  • Medication adherence is critical for pediatric liver transplant recipients.
  • Non-adherence can lead to poor medical outcomes, including graft rejection and liver dysfunction.
  • Tacrolimus blood levels are a key indicator of adherence in these patients.

Purpose of the Study:

  • To evaluate an adherence-improvement protocol for pediatric liver transplant patients.
  • To assess the impact of increased clinic visits on medical outcomes and medication adherence.
  • To determine the cost-effectiveness of the adherence intervention.

Main Methods:

  • A clinical program followed 23 children and adolescents undergoing liver transplant.
  • Non-adherent patients were identified using tacrolimus blood levels.
  • Intervention involved increasing clinic visit frequency for non-adherent patients.
  • Outcomes were compared between a two-year pre-intervention period and the intervention period.

Main Results:

  • The number of patients with high alanine aminotransferase levels (≥100) significantly decreased post-intervention (8 to 4).
  • Rejection episodes decreased from three pre-intervention to none post-intervention.
  • Improved adherence to tacrolimus was observed, though not statistically significant.
  • The intervention did not result in increased outpatient costs.

Conclusions:

  • An adherence-improvement intervention involving increased clinic visits shows promise for pediatric liver transplant recipients.
  • The protocol demonstrated potential in improving key medical outcomes.
  • Larger, controlled studies are necessary to confirm the efficacy of this intervention.

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...